Innovations in Evaluating Statin Benefit and Efficacy in Staphylococcus aureus Intracellular Infection Management
Open Access
- 27 October 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (21) , 13006
Abstract
An emerging therapeutic approach in the treatment of infectious disease is to augment the host response through repurposing of well-tolerated, non-antibiotic, host-directed therapeutics. Earlier retrospective studies identify a positive association between statin use and a decreased risk of death due to sepsis or bacteremia. However, more recent randomized control trials fail to detect a therapeutic benefit in these complex infection settings. It is postulated that unrecognized biases in certain observational studies may have led to an overestimation of benefit and that statin use is instead a marker for health status, wealth, and demographic characteristics which may separately affect death due to infection. What remains unresolved is that in vitro and in vivo evidence reproducibly indicates that statin pharmacology limits infection and augments immunomodulatory responses, suggesting that therapeutic benefits may be attainable in certain infection settings, such as intracellular infection by S. aureus. Carefully considering the biological mechanisms capable of driving the relationship between statins and infections and constructing a methodology to avoid potential biases in observational studies would enable the examination of protective effects against infection and limit the risk of underestimating statin efficacy. Such an approach would rely on the examination of statin use in defined infection settings based on an underlying mode-of-action and pharmacology, where the inhibition of HMG-CoA-reductase at the rate-limiting step in cholesterol biosynthesis diminishes not only cholesterol levels but also isoprenoid intermediates central to host cell invasion by S. aureus. Therapeutic benefit in such settings, if existent, may be of clinical importance.Keywords
This publication has 61 references indexed in Scilit:
- Risk factors for revision of primary total hip arthroplasty: a systematic reviewBMC Musculoskeletal Disorders, 2012
- Polymorphisms in fibronectin binding protein A of Staphylococcus aureus are associated with infection of cardiovascular devicesProceedings of the National Academy of Sciences, 2011
- Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infectionEMBO Molecular Medicine, 2011
- Statins Enhance Formation of Phagocyte Extracellular TrapsCell Host & Microbe, 2010
- Interaction of staphylococci with boneInternational Journal of Medical Microbiology, 2010
- GTPase activating protein function of p85 facilitates uptake and recycling of the β1 integrinBiochemical and Biophysical Research Communications, 2009
- Statin Adherence and Risk of AccidentsCirculation, 2009
- The Association Between Statins and Cancer Incidence in a Veterans PopulationJNCI: Journal of the National Cancer Institute, 2008
- Projections of Primary and Revision Hip and Knee Arthroplasty in the United States from 2005 to 2030Journal of Bone and Joint Surgery, 2007
- Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infectionsNature Reviews Microbiology, 2006